|
CREB3L2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.721100E-03 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.435400E-04 |
| Normal-vs-Stage2 |
1.830170E-01 |
| Normal-vs-Stage3 |
4.249700E-02 |
| Normal-vs-Stage4 |
8.588400E-02 |
| Stage1-vs-Stage2 |
5.097200E-01 |
| Stage1-vs-Stage3 |
8.250000E-01 |
| Stage1-vs-Stage4 |
5.959800E-01 |
| Stage2-vs-Stage3 |
6.951800E-01 |
| Stage2-vs-Stage4 |
3.979800E-01 |
| Stage3-vs-Stage4 |
5.504000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
4.798700E-03 |
| Normal-vs-AfricanAmerican |
3.441600E-03 |
| Normal-vs-Asian |
3.631600E-02 |
| Caucasian-vs-AfricanAmerican |
4.955400E-01 |
| Caucasian-vs-Asian |
5.710800E-01 |
| AfricanAmerican-vs-Asian |
7.134200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.151800E-04 |
| Normal-vs-Female |
6.484800E-01 |
| Male-vs-Female |
1.182350E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.358290E-04 |
| Normal-vs-Extreme_Weight |
2.542700E-03 |
| Normal-vs-Obese |
1.700230E-01 |
| Normal-vs-Extreme_Obese |
2.460000E-03 |
| Normal_Weight-vs-Extreme_Weight |
3.512400E-01 |
| Normal_Weight-vs-Obese |
2.416400E-02 |
| Normal_Weight-vs-Extreme_Obese |
7.468200E-01 |
| Extreme_Weight-vs-Obese |
1.503620E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.371400E-01 |
| Obese-vs-Extreme_Obese |
1.222420E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.583370E-01 |
| Normal-vs-Age(41-60Yrs) |
1.748630E-01 |
| Normal-vs-Age(61-80Yrs) |
6.05510000000198E-05 |
| Normal-vs-Age(81-100Yrs) |
5.003800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.787600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.735600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.406600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.524500E-03 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.742750E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
6.708600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
2.382200E-02 |
| Normal-VS-Type2 PRCC |
3.58830000046773E-07 |
| Normal-VS-KIRP CIMP |
5.827600E-01 |
| Normal-VS-Unclassified PRCC |
8.345400E-01 |
| Type1 PRCC-VS-Type2 PRCC |
3.214700E-04 |
| Type1 PRCC-VS-KIRP CIMP |
7.769000E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.645410E-01 |
| Type2 PRCC-VS-KIRP CIMP |
6.088100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.018700E-03 |
| KIRP CIMP-VS-Unclassified PRCC |
5.862400E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.382000E-04 |
| Normal-vs-N1 |
6.539100E-03 |
| Normal-vs-N2 |
6.307200E-01 |
| N0-vs-N1 |
7.498800E-01 |
| N0-vs-N2 |
5.517700E-02 |
| N1-vs-N2 |
3.308200E-01 |
|
|
